{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:49:52Z","timestamp":1772819392984,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T00:00:00Z","timestamp":1487808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA-022063"],"award-info":[{"award-number":["AA-022063"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National institute of Health","award":["S10OD016226"],"award-info":[{"award-number":["S10OD016226"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0172628","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T13:54:12Z","timestamp":1487858052000},"page":"e0172628","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells"],"prefix":"10.1371","volume":"12","author":[{"given":"Narasimha M.","family":"Midde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namita","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep B.","family":"Lukka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Meibohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7846-5674","authenticated-orcid":true,"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1345\/aph.1M309","article-title":"Integrase inhibitors: a novel class of antiretroviral agents","volume":"44","author":"JJ Schafer","year":"2010","journal-title":"The Annals of Pharmacotherapy"},{"key":"ref2","article-title":"What to Start | Adult and Adolescent ARV Guidelines","author":"A Guidelines","year":"2016","journal-title":"AIDSinfo"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3851\/IMP1397","article-title":"Elvitegravir: a new HIV integrase inhibitor","volume":"20","author":"K Shimura","year":"2009","journal-title":"Antivir Chem Chemother"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2174\/138920012802850119","article-title":"The cellular pharmacokinetics of HIV protease inhibitors: current knowledge and future perspectives","volume":"13","author":"W Zha","year":"2012","journal-title":"Curr Drug Metab"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/AAC.00036-07","article-title":"Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1","volume":"51","author":"J L\u00f6tsch","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2010.02301.x","article-title":"Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition","volume":"268","author":"F Josephson","year":"2010","journal-title":"J Intern Med"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/11318110-000000000-00000","article-title":"Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action","volume":"49","author":"C Bazzoli","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/AAC.06417-11","article-title":"Pharmacokinetics and pharmacodynamics of once-daily versus twice-daily raltegravir in treatment-naive HIV-infected patients","volume":"56","author":"ML Rizk","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref9","first-page":"190","article-title":"Elvitegravir, an oral HIV integrase inhibitor, for the potential treatment of HIV infection","volume":"10","author":"OM Klibanov","year":"2009","journal-title":"Current Opinion in Investigational Drugs (London, England: 2000)"},{"issue":"9835","key":"ref10","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/S0140-6736(12)60918-0","article-title":"Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial","volume":"379","author":"E DeJesus","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/jpet.107.131482","article-title":"Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells","volume":"324","author":"G Minuesa","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00003088-200746060-00001","article-title":"Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy","volume":"46","author":"K K\u00f6ck","year":"2007","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1002\/jps.22655","article-title":"Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors","volume":"100","author":"L Griffin","year":"2011","journal-title":"J Pharm Sci"},{"issue":"21\u201322","key":"ref14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.lfs.2010.09.012","article-title":"Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals","volume":"88","author":"D Pal","year":"2011","journal-title":"Life Sci"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/jac\/dkr151","article-title":"Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration","volume":"66","author":"A Fayet Mello","year":"2011","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"CV Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","article-title":"Alcohol metabolism","volume":"16","author":"AI Cederbaum","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1530-0277.2010.01330.x","article-title":"Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages","volume":"35","author":"M Jin","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"ref19","article-title":"Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc\/jnk\/sp1 pathway","volume":"4","author":"M Jin","year":"2013","journal-title":"Cell Death Dis"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/acer.12938","article-title":"Chronic Effects of Ethanol and\/or Darunavir\/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity","volume":"40","author":"PS Rao","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/AAC.44.6.1686-1690.2000","article-title":"Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults","volume":"44","author":"JA McDowell","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/515642","article-title":"Relative potency of protease inhibitors in monocytes\/macrophages acutely and chronically infected with human immunodeficiency virus","volume":"178","author":"CF Perno","year":"1998","journal-title":"J Infect Dis"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/157016208785861195","article-title":"Cellular reservoirs of HIV-1 and their role in viral persistence","volume":"6","author":"A Alexaki","year":"2008","journal-title":"Curr HIV Res"},{"issue":"21","key":"ref24","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2174\/0929867023368935","article-title":"The role of monocytes and macrophages in the pathogenesis of HIV-1 infection","volume":"9","author":"K Kedzierska","year":"2002","journal-title":"Curr Med Chem"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"e0149225","DOI":"10.1371\/journal.pone.0149225","article-title":"Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir\/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS\/MS Method","volume":"11","author":"NM Midde","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1538-7836.2005.01781.x","article-title":"In-cell Western assay: a new approach to visualize tissue factor in human monocytes","volume":"4","author":"EM Egorina","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nmeth.2992","article-title":"Single-cell western blotting","volume":"11","author":"AJ Hughes","year":"2014","journal-title":"Nat Methods"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/ADM.0b013e318293655a","article-title":"Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz","volume":"7","author":"EF McCance-Katz","year":"2013","journal-title":"J Addict Med"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/2325957413495567","article-title":"Interactions between alcohol and the HIV entry inhibitor Maraviroc","volume":"12","author":"VA Gruber","year":"2013","journal-title":"Journal of the International Association of Providers of AIDS Care"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s40262-014-0190-x","article-title":"Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol)","volume":"53","author":"L-N Chan","year":"2014","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/03602532.2011.560607","article-title":"Toward a new age of cellular pharmacokinetics in drug discovery","volume":"43","author":"F Zhou","year":"2011","journal-title":"Drug Metab Rev"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/AAC.01064-10","article-title":"Identification and characterization of persistent intracellular human immunodeficiency virus type 1 integrase strand transfer inhibitor activity","volume":"55","author":"Y Koh","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jac\/dku556","article-title":"Pharmacokinetic profile of raltegravir, elvitegravir and dolutegravir in plasma and mucosal secretions in rhesus macaques","volume":"70","author":"I Massud","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1089\/aid.2013.0031","article-title":"Increasing extracellular protein concentration reduces intracellular antiretroviral drug concentration and antiviral effect","volume":"29","author":"LB Avery","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1570162X12666140721124923","article-title":"Alcohol enhances HIV infection of cord blood monocyte-derived macrophages","volume":"12","author":"DS Mastrogiannis","year":"2014","journal-title":"Curr HIV Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3389\/fmicb.2015.01452","article-title":"Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC)","volume":"6","author":"M Agudelo","year":"2015","journal-title":"Front Microbiol"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/infdis\/167.4.789","article-title":"Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells","volume":"167","author":"O Bagasra","year":"1993","journal-title":"J Infect Dis"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.qai.0000233308.82860.2f","article-title":"Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients","volume":"43","author":"E DeJesus","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/jac\/dkt220","article-title":"In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir","volume":"68","author":"F Canducci","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"4828","key":"ref40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.3313729","article-title":"Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line","volume":"238","author":"TM Folks","year":"1987","journal-title":"Science (New York, NY)"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1248\/bpb.25.383","article-title":"Cytochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines","volume":"25","author":"F Nagai","year":"2002","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1530-0277.2011.01575.x","article-title":"Differential effects of ethanol on spectral binding and inhibition of cytochrome P450 3A4 with eight protease inhibitors antiretroviral drugs","volume":"35","author":"S Kumar","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbrc.2010.10.014","article-title":"Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir","volume":"402","author":"S Kumar","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1530-0277.2003.tb04424.x","article-title":"Induction of CYP3A by ethanol in multiple in vitro and in vivo models","volume":"27","author":"DE Feierman","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1006\/abbi.1995.1495","article-title":"Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes","volume":"322","author":"VE Kostrubsky","year":"1995","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/0006-2952(95)00098-K","article-title":"Rapid changes in cytochrome P4502E1 (CYP2E1) activity and other P450 isozymes following ethanol withdrawal in rats","volume":"49","author":"BJ Roberts","year":"1995","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0091270009343696","article-title":"Influence of development, HIV infection, and antiretroviral therapies on the gene expression profiles of ABC transporters in human lymphocytes","volume":"50","author":"C Giraud","year":"2010","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/jmv.21152","article-title":"Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy","volume":"80","author":"O Turriziani","year":"2008","journal-title":"J Med Virol"},{"key":"ref49","article-title":"Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro","author":"NCL Zembruski","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref50","article-title":"Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets","author":"TJ Cory","year":"2016","journal-title":"Pharm Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0172628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T07:10:24Z","timestamp":1540019424000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0172628"}},"subtitle":[],"editor":[{"given":"Fatah","family":"Kashanchi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0172628","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}